![Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for success - Soni - 2020 - American Journal of Hematology - Wiley Online Library Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for success - Soni - 2020 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/572e4fa8-e370-41df-a173-6bc22c438ed6/ajh25909-fig-0001-m.jpg)
Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for success - Soni - 2020 - American Journal of Hematology - Wiley Online Library
![Luspatercept for the treatment of β-thalassemia: from preclinical research to clinical practice and beyond | Future Rare Diseases Luspatercept for the treatment of β-thalassemia: from preclinical research to clinical practice and beyond | Future Rare Diseases](https://www.futuremedicine.com/cms/10.2217/frd-2021-0012/asset/images/medium/figure1.gif)
Luspatercept for the treatment of β-thalassemia: from preclinical research to clinical practice and beyond | Future Rare Diseases
![IJMS | Free Full-Text | Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis IJMS | Free Full-Text | Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis](https://www.mdpi.com/ijms/ijms-19-04070/article_deploy/html/images/ijms-19-04070-g001.png)
IJMS | Free Full-Text | Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis
![PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy](https://i1.rgstatic.net/publication/311339660_Cure_for_thalassemia_major_-_From_allogeneic_hematopoietic_stem_cell_transplantation_to_gene_therapy/links/59b7f5cd0f7e9bd4a7ff1be6/largepreview.png)
PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy
![Cureus | Efficacy and Safety of Luspatercept in the Treatment of β- Thalassemia: A Systematic Review | Article Cureus | Efficacy and Safety of Luspatercept in the Treatment of β- Thalassemia: A Systematic Review | Article](https://assets.cureus.com/uploads/figure/file/482555/lightbox_653de1c0503011ed94fa7db5f72f1af1-Swr-1.png)
Cureus | Efficacy and Safety of Luspatercept in the Treatment of β- Thalassemia: A Systematic Review | Article
![Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia: Molecular Therapy Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia: Molecular Therapy](https://www.cell.com/cms/attachment/08d4beb7-ced4-4121-a27b-afcdfb311cfe/fx1_lrg.jpg)
Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia: Molecular Therapy
![Frontiers | Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene Frontiers | Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene](https://www.frontiersin.org/files/Articles/752278/fgeed-03-752278-HTML/image_m/fgeed-03-752278-g003.jpg)
Frontiers | Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene
![Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia](https://www.mdpi.com/biomolecules/biomolecules-11-00755/article_deploy/html/images/biomolecules-11-00755-g001.png)
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
![Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis](https://www.mdpi.com/diseases/diseases-10-00085/article_deploy/html/images/diseases-10-00085-g001.png)
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
![Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu](https://image.isu.pub/220523125456-31254084c0fc681ef531a9580454bbd7/jpg/page_1.jpg)
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
![Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-00169-x/MediaObjects/41598_2021_169_Fig1_HTML.png)
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports
![Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study - The Lancet Global Health Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study - The Lancet Global Health](https://www.thelancet.com/cms/attachment/77794f9a-7ee5-4886-8e74-bcb75b3a1430/gr1_lrg.jpg)
Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study - The Lancet Global Health
![Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells](https://www.frontiersin.org/files/MyHome%20Article%20Library/730873/730873_Thumb_400.jpg)